MedPath

Comparison of Quality of life (QOL) in medical and surgical therapies of glaucoma

Not Applicable
Conditions
Health Condition 1: H409- Unspecified glaucoma
Registration Number
CTRI/2020/05/025441
Lead Sponsor
Government Medical college and Hospital Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Group I: Patients of moderate and severe glaucoma on medical therapy for a period of 3 months to 1 year.

•Group II: Patients who have undergone glaucoma filtration surgery in the form of trabeculectomy at least 3 months before the study.

•Group III: Patients who have undergone a glaucoma drainage device placement at least 3 months before the study.

Exclusion Criteria

Patients with already compromised quality of life owing to physical disability, hearing disability or neuropsychiatric conditions.

Patients who had a trabeculectomy/implant surgery within the 3 months preceding the study period.

Patients with other eye diseases such as visually significant cataract, disorders affecting the retina like diabetic retinopathy, diabetic maculopathy, hypertensive retinopathy, age related macular degeneration (ARMD).

Patients who underwent a cataract surgery in combination with the trabeculectomy in the same sitting (phacotrabeculectomy).

Patients of mild glaucoma or those on monotherapy(receiving single drug therapy)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath